Fesoterodine Fumarate Tablet, Film Coated, Extended Release
Product Images NDC 72603-413

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fesoterodine Fumarate (NDC 72603-413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

4mg-30s (4mg 30s)

4mg-30s (4mg 30s)
The text provides information about an extended-release tablet containing 4 mg of fesoterodine fumarate. The tablet should be swallowed whole and not chewed, divided, or crushed. It is advised to store the medication at a temperature between 20°C to 25°C to protect it from moisture. The manufacturing information indicates that the tablets are manufactured for Northstar Rx LLC in Memphis, TN, and by Annora Pharma Pvt. Ltd. in Telangana, India.*
FDA Label Image

8mg-30s (8mg 30s)

8mg-30s (8mg 30s)
Each extended-release, film-coated tablet contains 8 mg of fesoterodine fumarate. The tablets should be swallowed whole and should not be chewed, divided, or crushed. The usual dosage information can be found in the package insert. These tablets should be stored at 20°C to 25°C and protected from moisture. The product is manufactured by Northstar Rx LLC and Annora Pharma Pvt. Ltd. This medication is a product of India.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text provides information on the change in urge incontinence episodes per 24 hours in Study 1. It shows the decrease in episodes for two different groups treated with Fesoterodine Fumarate extended-release tablets: one with a dosage of 4 mg (N=199) and the other with a dosage of 8 mg (N=225).*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.